|
Market Closed -
Nasdaq
16:00:00 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 14.83 USD | +3.06% |
|
+6.00% | +58.10% |
| 08-03 | Design Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-03 | Design Therapeutics Q2 Net Loss Narrows | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
DSGN 14.83 $
+3.06%
3.85M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| DSGN | 14.83USD | +3.06% | 3.85M $ | |
CBOE
| DSGN | 14.82USD | +2.95% | 129K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 15.79 | 15.79 | 15.64 |
| Spread/Res. | -6.08% | -6.08% | -5.18% |
| Spread/Supp. | +27.52% | +48.45% | +59.81% |
| Support | 11.63 | 9.99 | 9.28 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- DSGN Stock
- Charts Design Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
